Gradient Investments LLC Illumina, Inc. Transaction History

Gradient Investments LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$127.73 - $147.2 $35,764 - $41,216	-280 Reduced 98.25%	5 $0
Q4 2023 Jan 18, 2024	BUY	$92.79 - $142.53 $20,877 - $32,069	225 Added 375.0%	285 $39,000
Q2 2023 Jul 11, 2023	BUY	$183.43 - $232.67 $1,834 - $2,326	10 Added 20.0%	60 $11,000
Q4 2022 Jan 10, 2023	SELL	$187.24 - $242.74 $748 - $970	-4 Reduced 7.41%	50 $0
Q3 2022 Oct 14, 2022	BUY	$177.23 - $227.44 $708 - $909	4 Added 8.0%	54 $10,000
Q1 2020 Apr 07, 2020	SELL	$209.2 - $335.53 $627 - $1,006	-3 Reduced 5.66%	50 $14,000
Q4 2019 Jan 15, 2020	SELL	$288.29 - $335.49 $1,441 - $1,677	-5 Reduced 8.62%	53 $18,000
Q3 2019 Oct 10, 2019	BUY	$266.84 - $378.23 $2,134 - $3,025	8 Added 16.0%	58 $18,000
Q2 2019 Jul 16, 2019	BUY	$300.59 - $368.15 $15,029 - $18,407	50 New	50 $18,000
Q1 2019 Apr 11, 2019	SELL	$272.57 - $321.18 $2,998 - $3,532	-11 Closed	0 $0
Q4 2018 Jan 18, 2019	BUY	$272.46 - $366.54 $2,997 - $4,031	11 New	11 $3,000
Q1 2018 Apr 11, 2018	SELL	$209.54 - $253.91 $838 - $1,015	-4 Closed	0 $0
Q4 2017 Feb 07, 2018	BUY	$202.23 - $230.03 $808 - $920	4	4 $1,000

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Gradient Investments LLC with notifications on news.